>Reed Elsevier at a glance
----------

>Financial highlights
----------

>Report of the Chairman and the CEO
----------

>Directors
----------

>Operating and financial review
----------

>Product review
----------

>Corporate social responsibility
----------

>Corporate governance
----------

>Summary financial statements
----------

>Investor information
----------

>Annual Report and downloads
----------

 

 

>Introduction
----------

>Science & Medical
----------

>Legal
----------

>Education
----------

>Business
----------

>Reed Elsevier Combined
----------

>Reed Elsevier PLC
----------

>Reed Elsevier NV
----------

>Highlights
----------

>Turnover
----------

>Adjusted operating profit
----------

>Adjusted pre-tax profit
----------

>Adjusted operating cash flow
----------

>Introduction
----------

>Financial results
----------

>Progress on strategy
----------

>Parent company earnings and dividends
----------

>Board changes
----------

>Outlook
----------

>Directors’ biographies
----------

>Summary directors’ remuneration report
----------

>Remuneration policy
----------

>Total shareholder return
----------

>Directors’ emoluments
----------

>Summary of executive share options
 and shareholdings
----------

>Reed Elsevier combined businesses
----------

>Review of operations
----------

>Science & Medical
----------

>Legal
----------

>Education
----------

>Business
----------

>Parent companies
----------

>Forward looking statements
----------

>Introduction
----------

>Science & Medical
----------

>Legal
----------

>Education
----------

>Business
----------

>Introduction
----------

>Facts and figures
----------

>Introduction
----------

>Facts and figures
----------

>Introduction
----------

>Facts and figures
----------

>Introduction
----------

>Facts and figures
----------

>Valuing our people
----------

>Environment
----------

>Community
----------

>Introduction
----------

>Summary report of the directors
----------

>Basis of preparation
----------

>Auditors’ statement
----------

>Summary combined financials
----------

>Reed Elsevier PLC summary financials
----------

>Reed Elsevier NV summary financials
----------

>Summary combined profit and loss account
----------

>Summary combined cash flow statement
----------

>Summary combined balance sheet
----------

>Adjusted figures
----------

>Summary consolidated profit and
 loss account
----------

>Dividends
----------

>Consolidated statement of total recognised
 gains and losses
----------

>Summary consolidated cash flow statement
----------

>Reconciliation of shareholders’ funds
----------

>Summary consolidated balance sheet
----------

>Summary profit and loss account
----------

>Dividends
----------

>Summary cash flow statement
----------

>Reconciliation of shareholders’ funds
----------

>Summary balance sheeet
----------

>Structure
----------

>Corporate governance
----------

>Boards
----------

>Committees
----------

>Internal control
----------

>Going concern
----------

>Shareholder information
----------

>Financial calendar
----------

>Registered offices
----------

>Share price information
----------

>Information for Reed Elsevier PLC
 ordinary shareholders
----------

>Information for Reed Elsevier NV
 ordinary shareholders
----------

>Information for Reed Elsevier PLC
 and Reed Elsevier NV ADS holders
----------

Reed Elsevier Annual review and summary financial statements 2002
 Man with electronic equipment

Science & Medical

Elsevier performed well in 2002, growing ahead of its market. In Science and Technology subscription renewals for our products were strong, and migration to electronic only contracts accelerated. In Health Sciences we saw increased demand from the medical profession both for books and for online and PDA based services.

BioMedNet, Elsevier’s life sciences portal is one of the most visited publishers’ sites for life scientists. The service has over 500,000 active users who access BioMedNet as a gateway for information in all major life science disciplines. Registered users are also offered subscription-based services, including BioMedNet Reviews, the world’s largest and most often cited collection of specialist review articles focusing on the life sciences and including more than 30,000 articles. Elsevier logo
   
1 2 i ii 3 4 5
© 2003 Reed Elsevier | Forward looking statements | www.reedelsevier.com